Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies

被引：4
|
作者：
Tousi, Babak [1 ]
Sabbagh, Marwan Noel [2 ]
机构：
[1] Cleveland Clin, Ctr Brain Hlth, Cleveland, OH 44106 USA
[2] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA
来源：
NEUROLOGY AND THERAPY | 2021年 / 10卷 / 02期
关键词：
Monoclonal antibodies; Aducanumab; Disease-modifying treatments; Alzheimer's disease; Mild cognitive impairment; MILD COGNITIVE IMPAIRMENT; DEMENTIA; QUESTIONNAIRE;
D O I：
10.1007/s40120-021-00286-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：409 / 413
页数：5
相关论文
共 50 条
  • [1] Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
    Babak Tousi
    Marwan Noel Sabbagh
    Neurology and Therapy, 2021, 10 : 409 - 413
  • [2] Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
    Cummings J.
    Osse A.M.L.
    Cammann D.
    Powell J.
    Chen J.
    BioDrugs, 2024, 38 (1) : 5 - 22
  • [3] Monoclonal anti-amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician
    Chin, Nathaniel A.
    Widera, Eric
    Brangman, Sharon A.
    Karlawish, Jason
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (02) : 643 - 645
  • [4] CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease
    David Knopman
    Mary Sano
    Howard H. Feldman
    Nature Reviews Neurology, 2022, 18 : 379 - 380
  • [5] Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
    Jeffrey Cummings
    Drugs, 2023, 83 : 569 - 576
  • [6] Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
    Cummings, Jeffrey
    DRUGS, 2023, 83 (07) : 569 - 576
  • [7] Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies
    Rygiel, Katarzyna
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (06) : 629 - 636
  • [8] CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease COMMENT
    Knopman, David
    Sano, Mary
    Feldman, Howard H.
    NATURE REVIEWS NEUROLOGY, 2022, 18 (07) : 379 - 380
  • [9] Pros of Anti-Amyloid Monoclonal Antibodies
    Rabinovici, Gil
    ANNALS OF NEUROLOGY, 2023, 94 : S281 - S282
  • [10] Cons of Anti-Amyloid Monoclonal Antibodies
    Thambisetty, Madhav
    ANNALS OF NEUROLOGY, 2023, 94 : S282 - S282
12345